These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31213295)

  • 21. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents.
    Dinter H; Tse J; Halks-Miller M; Asarnow D; Onuffer J; Faulds D; Mitrovic B; Kirsch G; Laurent H; Esperling P; Seidelmann D; Ottow E; Schneider H; Tuohy VK; Wachtel H; Perez HD
    J Neuroimmunol; 2000 Aug; 108(1-2):136-46. PubMed ID: 10900347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amelioration of experimental autoimmune encephalitis by novel peptides: involvement of T regulatory cells.
    Shapira E; Brodsky B; Proscura E; Nyska A; Erlanger-Rosengarten A; Wormser U
    J Autoimmun; 2010 Aug; 35(1):98-106. PubMed ID: 20434883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.
    Linker RA; Lee DH; Demir S; Wiese S; Kruse N; Siglienti I; Gerhardt E; Neumann H; Sendtner M; Lühder F; Gold R
    Brain; 2010 Aug; 133(Pt 8):2248-63. PubMed ID: 20826430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.
    Binyamin O; Larush L; Frid K; Keller G; Friedman-Levi Y; Ovadia H; Abramsky O; Magdassi S; Gabizon R
    Int J Nanomedicine; 2015; 10():7165-74. PubMed ID: 26648720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
    Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis.
    Aharoni R; Saada R; Eilam R; Hayardeny L; Sela M; Arnon R
    J Neuroimmunol; 2012 Oct; 251(1-2):14-24. PubMed ID: 22749337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
    Mondal S; Pahan K
    PLoS One; 2015; 10(1):e0116566. PubMed ID: 25569428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
    Elliott DM; Singh N; Nagarkatti M; Nagarkatti PS
    Front Immunol; 2018; 9():1782. PubMed ID: 30123217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
    De Santi L; Annunziata P; Sessa E; Bramanti P
    J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.
    Pryce G; Riddall DR; Selwood DL; Giovannoni G; Baker D
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):281-92. PubMed ID: 25537576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain.
    Barnes MP
    Expert Opin Pharmacother; 2006 Apr; 7(5):607-15. PubMed ID: 16553576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoids and multiple sclerosis.
    Pertwee RG
    Pharmacol Ther; 2002 Aug; 95(2):165-74. PubMed ID: 12182963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-alpha and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE).
    Penkowa M; Hidalgo J
    Exp Neurol; 2001 Jul; 170(1):1-14. PubMed ID: 11421579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS).
    KhorshidAhmad T; Acosta C; Cortes C; Lakowski TM; Gangadaran S; Namaka M
    Mol Neurobiol; 2016 Mar; 53(2):1092-1107. PubMed ID: 25579386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis.
    Liu Y; Zhu B; Wang X; Luo L; Li P; Paty DW; Cynader MS
    J Neuroimmunol; 2003 Jun; 139(1-2):27-35. PubMed ID: 12799017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis.
    Achiron A; Miron S; Lavie V; Margalit R; Biegon A
    J Neuroimmunol; 2000 Jan; 102(1):26-31. PubMed ID: 10626663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain.
    Khan N; Kuo A; Brockman DA; Cooper MA; Smith MT
    Inflammopharmacology; 2018 Feb; 26(1):77-86. PubMed ID: 28965161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains.
    Chung IY; Norris JG; Benveniste EN
    J Exp Med; 1991 Apr; 173(4):801-11. PubMed ID: 1901078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Marijuana Compounds on Neuroimmune Endpoints in Experimental Autoimmune Encephalomyelitis.
    Kaplan BLF
    Curr Protoc Toxicol; 2018 Feb; 75():11.25.1-11.25.22. PubMed ID: 29512125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.